Victory Pharma: Paying Doctors to Let Sales Reps Follow Them

The Victory Pharma kickback settlement included a $9,938,310 civil payment to resolve allegations that the company paid doctors to prescribe its drugs. The government described entertainment, expensive dinners and paid office visits in which sales representatives shadowed doctors in their offices. A former sales representative brought the whistleblower case. For someone who arranged the visits or approved the spending, the revealing question is what the company expected the doctor to do afterward.

Victory Pharma was a specialty pharmaceutical company headquartered in San Diego. The Justice Department announced the settlement on December 27, 2012. This pharmaceutical fraud case concerned the benefits used to generate prescriptions for particular products, including prescriptions for patients covered by Medicare and other federal health insurance programs.

Naprelan, Xodol, Fexmid and Dolgic

Naprelan, Xodol, Fexmid and Dolgic were the four products named in the Victory resolution. The government alleged that Victory used kickbacks to doctors to induce prescriptions for its products. The benefit went to the person deciding which medicine the patient would receive.

The alleged entertainment ranged from sporting events and concerts to spa visits, ski outings and expensive dinners. The alleged return was prescribing business.

The patient was relying on the doctor’s medical judgment. Taxpayers helped pay for prescriptions covered by federal programs. According to the government’s allegations, Victory inserted a private benefit into that decision: the company paid for something the doctor enjoyed, then sought prescriptions for the company’s drugs.

Paid Preceptorships Put Sales Reps Inside the Office

The government alleged that Victory encouraged its sales representatives to arrange paid preceptorships. In the Justice Department’s description, that meant representatives shadowing doctors in their offices. The government alleged that Victory improperly used those arrangements to induce prescriptions.

In the alleged scheme, the payment made the doctor’s office itself part of the promotional arrangement. A representative could accompany the person making prescribing decisions, while that person received a benefit from the company whose products the representative sold. That is the part a sales employee would recognize immediately: who arranged the visit, which doctor received it and what management wanted from the relationship.

For a paid office program, we examine the work described in the agreement against the work actually done. What was the doctor expected to teach or provide? What did the representative do during the visit? How did the company choose the doctors, and what did managers say about the prescriptions they expected? Those questions connect the payment to its purpose.

The representative’s instructions and account of the visit can explain how it operated. In Victory’s case, the government’s allegation went directly to that purpose: paid time alongside a doctor was being used to encourage that doctor to prescribe Victory products.

The Prescriber Got the Benefit, the Public Got the Bill

The alleged sales incentive reached public money through prescriptions for federally insured patients. That connection explains why the Victory case produced a False Claims Act settlement.

In the pharmaceutical supply chain, a medicine can move from manufacturer to wholesaler to dispenser. The prescribing decision steers which product moves through that chain. A pharmacy or physician can submit the payment claim while the manufacturer supplies the inducement behind the prescription.

The 2021 review Risks of Corruption in the Healthcare and Pharmaceutical Sector and the Impact of a Pandemic, published in Proceedings: Security Challenges During COVID-19, maps opportunities for influence at separate stages of the medicine business. It identifies gifts and financial incentives during marketing, then the clinician’s ability to steer patients toward a particular medicine when prescribing treatment. That separation helps explain the Victory allegation: the sales expense was upstream of the prescription and the public payment.

We connect the company’s spending and sales instructions with prescribing and payment records, working with the insider who knows what happened.

A Former Sales Representative Brought the Case

A former Victory sales representative filed the False Claims Act lawsuit resolved by the settlement. The Justice Department announced a $1.7 million whistleblower award as part of the resolution.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

Victory’s alleged arrangements involved sales representatives scheduling paid visits with doctors. A sales employee’s firsthand account connects the instructions for a visit with what happened in the office. That firsthand perspective is central to how we assess a pharmaceutical whistleblower’s case.

What Evidence Is Needed to Prove Fraud?

With an insider, we compare agreements, invitations, calendars and expense records with the instructions that drove the program. The useful detail is often a decision: who selected a doctor, who approved the payment and what result they wanted.

The person who attended an event can also explain what an attendance sheet leaves out. A related allegation appears in the speaker-program case involving Biohaven’s Nurtec. The whistleblower’s complaint alleged that representatives were expected to pay speakers even without a prescribing audience:

The complaint further alleged that representatives were told to invite office staff and pharmacy students to supply names for sign-in sheets and justify food costs. The government’s January 2025 settlement announcement resolved allegations that Biohaven paid healthcare providers to induce Nurtec ODT prescriptions.

That parallel shows why an insider’s account of an event matters. A populated attendance sheet can tell a different story from the person who knows why the attendees were invited. For a paid preceptorship, the comparable work is connecting the promised service, the office visit and the sales purpose.

You Know What the Visit Was Meant to Buy

If you arranged paid office visits or prescriber entertainment and know what the sales team expected in return, speak to one of our whistleblower experts about what those visits were meant to buy. We build your strongest pharmaceutical whistleblower case with you, bring in pharmaceutical kickback whistleblower lawyers who understand prescriber payments, and stay beside you through the process.